147 related articles for article (PubMed ID: 23872604)
1. Rat hepatocyte culture model of macrosteatosis: effect of macrosteatosis induction and reversal on viability and liver-specific function.
Nativ NI; Yarmush G; Chen A; Dong D; Henry SD; Guarrera JV; Klein KM; Maguire T; Schloss R; Berthiaume F; Yarmush ML
J Hepatol; 2013 Dec; 59(6):1307-14. PubMed ID: 23872604
[TBL] [Abstract][Full Text] [Related]
2. Elevated sensitivity of macrosteatotic hepatocytes to hypoxia/reoxygenation stress is reversed by a novel defatting protocol.
Nativ NI; Yarmush G; So A; Barminko J; Maguire TJ; Schloss R; Berthiaume F; Yarmush ML
Liver Transpl; 2014 Aug; 20(8):1000-11. PubMed ID: 24802973
[TBL] [Abstract][Full Text] [Related]
3. Steatosis reversibly increases hepatocyte sensitivity to hypoxia-reoxygenation injury.
Berthiaume F; Barbe L; Mokuno Y; MacDonald AD; Jindal R; Yarmush ML
J Surg Res; 2009 Mar; 152(1):54-60. PubMed ID: 18599084
[TBL] [Abstract][Full Text] [Related]
4. Prevention of reperfusion injury and microcirculatory failure in macrosteatotic mouse liver by omega-3 fatty acids.
El-Badry AM; Moritz W; Contaldo C; Tian Y; Graf R; Clavien PA
Hepatology; 2007 Apr; 45(4):855-63. PubMed ID: 17393510
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-33 / Cyclin D1 imbalance in severe liver steatosis predicts susceptibility to ischemia reperfusion injury.
Núñez KG; Frank A; Gonzalez-Rosario J; Galliano G; Bridle K; Crawford D; Seal J; Abbruscato F; Vashistha H; Thevenot PT; Cohen AJ
PLoS One; 2019; 14(4):e0216242. PubMed ID: 31034519
[TBL] [Abstract][Full Text] [Related]
6. An approach to the rational use of steatotic donor livers in liver transplantation.
Urena MA; Moreno Gonzalez E; Romero CJ; Ruiz-Delgado FC; Moreno Sanz C
Hepatogastroenterology; 1999; 46(26):1164-73. PubMed ID: 10370686
[TBL] [Abstract][Full Text] [Related]
7. CFD assessment of the effect of convective mass transport on the intracellular clearance of intracellular triglycerides in macrosteatotic hepatocytes.
Yarmush G; Santos L; Yarmush J; Koundinyan S; Saleem M; Nativ NI; Yarmush ML; Berthiaume F; Maguire TJ; Guaghan C
Biomech Model Mechanobiol; 2017 Aug; 16(4):1095-1102. PubMed ID: 28220319
[TBL] [Abstract][Full Text] [Related]
8. Altered alkaline phosphatase activity in obese Zucker rats liver respect to lean Zucker and Wistar rats discussed in terms of all putative roles ascribed to the enzyme.
Bertone V; Tarantola E; Ferrigno A; Gringeri E; Barni S; Vairetti M; Freitas I
Eur J Histochem; 2011 Feb; 55(1):e5. PubMed ID: 21556120
[TBL] [Abstract][Full Text] [Related]
9. A rapid and reliable means of assessing hepatic steatosis in vivo via electrical bioimpedance.
Hessheimer AJ; Parramón D; Guimerà A; Erill I; Rimola A; García-Valdecasas JC; Villa R; Fondevila C
Transplantation; 2009 Sep; 88(5):716-22. PubMed ID: 19741471
[TBL] [Abstract][Full Text] [Related]
10. Moderately Macrosteatotic Livers Have Acceptable Long-Term Outcomes but Higher Risk of Immediate Mortality.
Alvikas J; Deeb AP; Jorgensen DR; Minervini MI; Demetris AJ; Lemon K; Chen X; Labiner H; Malik S; Hughes C; Humar A; Tevar A
Transplant Proc; 2021 Jun; 53(5):1682-1689. PubMed ID: 33931249
[TBL] [Abstract][Full Text] [Related]
11. Effects of steatosis on drug-metabolizing capability of primary human hepatocytes.
Donato MT; Jiménez N; Serralta A; Mir J; Castell JV; Gómez-Lechón MJ
Toxicol In Vitro; 2007 Mar; 21(2):271-6. PubMed ID: 16950596
[TBL] [Abstract][Full Text] [Related]
12. Potential impact of steatosis on cytochrome P450 enzymes of human hepatocytes isolated from fatty liver grafts.
Donato MT; Lahoz A; Jiménez N; Pérez G; Serralta A; Mir J; Castell JV; Gómez-Lechón MJ
Drug Metab Dispos; 2006 Sep; 34(9):1556-62. PubMed ID: 16763015
[TBL] [Abstract][Full Text] [Related]
13. Steatosis among living liver donors without evidence of fatty liver on ultrasonography: potential implications for preoperative liver biopsy.
Ahn JS; Sinn DH; Gwak GY; Kim JM; Kwon CH; Joh JW; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC
Transplantation; 2013 Jun; 95(11):1404-9. PubMed ID: 23542472
[TBL] [Abstract][Full Text] [Related]
14. Hepatocyte transplantation from steatotic liver in a rat model.
Hayashi K; Aoki T; Jin Z; Wang H; Nishino N; Kusano T; Yasuda D; Koizumi T; Enami Y; Odaira M; Yamada K; Mitamura K; Niiya T; Murai N; Kato H; Shimizu Y; Kusano M
J Surg Res; 2007 Sep; 142(1):104-12. PubMed ID: 17604052
[TBL] [Abstract][Full Text] [Related]
15. Optimization of rat hepatocyte culture in citrated human plasma.
Washizu J; Berthiaume F; Chan C; Tompkins RG; Toner M; Yarmush ML
J Surg Res; 2000 Oct; 93(2):237-46. PubMed ID: 11027466
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of drug-metabolizing and functional competence of human hepatocytes incubated under hypothermia in different media for clinical infusion.
Gómez-Lechón MJ; Lahoz A; Jiménez N; Bonora A; Castell JV; Donato MT
Cell Transplant; 2008; 17(8):887-97. PubMed ID: 19069632
[TBL] [Abstract][Full Text] [Related]
17. Links between donor macrosteatosis, interleukin-33 and complement after liver transplantation.
Núñez K; Hamed M; Fort D; Bruce D; Thevenot P; Cohen A
World J Transplant; 2020 May; 10(5):117-128. PubMed ID: 32864357
[TBL] [Abstract][Full Text] [Related]
18. Biosynthesis of hippurate, urea and pyrimidines in the fatty liver: studies with rats fed orotic acid or a diet deficient in choline and inositol, and with genetically obese (Zucker) rats.
Maswoswe SM; Tremblay GC
J Nutr; 1989 Feb; 119(2):273-9. PubMed ID: 2918401
[TBL] [Abstract][Full Text] [Related]
19. Hepatic steatosis in liver transplant donors: rare phenomenon or common feature of donor population?
Hałoń A; Patrzałek D; Rabczyński J
Transplant Proc; 2006; 38(1):193-5. PubMed ID: 16504700
[TBL] [Abstract][Full Text] [Related]
20. Metabolic preconditioning of donor organs: defatting fatty livers by normothermic perfusion ex vivo.
Nagrath D; Xu H; Tanimura Y; Zuo R; Berthiaume F; Avila M; Yarmush R; Yarmush ML
Metab Eng; 2009; 11(4-5):274-83. PubMed ID: 19508897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
